Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-04-020613
Filing Date
2004-04-14
Accepted
2004-04-14 15:56:53
Documents
2
Period of Report
2004-04-14

Document Format Files

Seq Description Document Type Size
1 rrd38675.html 3  
1 rrd38675.xml 3 6642
3 POWER OF ATTORNEY rrd30238_35040.htm EX-24. 1315
  Complete submission text file 0001181431-04-020613.txt   9614
Mailing Address
Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENESOFT PHARMACEUTICALS INC 7300 SHORELINE COURT S SAN FRANCISCO CA 94080
Business Address
SINGER DAVID B (Reporting) CIK: 0001240366 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 04733139